Biotech Values

[InTheTrenches]

Can you show me an Alzheimer's trial that improved SIB scores by 4-8 points vs placebo in moderate-to-severe patients at week 13 (the final SIB test)? That is the goal.

This is a phase 2 trial, so if successful, I expect the FDA will require a longer (30 week) phase 3 trial. My hope is that management will partner to take this to the next level.